FindTrial
Sign In

Diclofenac Patch vs inj paracetamol Following Cesarean Delivery

A Randomised Controlled Trial for Evaluation of Transdermal Diclofenac Patch with inj paracetamol as an Analgesic Drug Following Cesarean Delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029204
Enrollment
200
Registered
2020-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O82- Encounter for cesarean delivery without indication

Interventions

None listed

Sponsors

Armed Forces Medical College Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ll women undergoing elective caesarean delivery at term with singleton pregnancy

Exclusion criteria

Exclusion criteria: Emergency caesarean delivery Preterm caesarean delivery Intraoperative complication Postpartum hemorrhage NSAID allergy

Design outcomes

Primary

MeasureTime frame
Measurement for the intensity of pain postoperatively at 6, 12, 18 and 24 hours by visual analogue scale (VAS) of 0 -10 points.Timepoint: Measurement for the intensity of pain postoperatively at 6, 12, 18 and 24 hours by visual analogue scale (VAS) of 0 -10 points.—

Secondary

MeasureTime frame
Secondary end point Number of times rescue analgesic required. Timepoint: 6hrs 12hrs 18hrs 24hrs—

Countries

India

Contacts

Public ContactDR SUSHIL CHAWLA

AFMC

chawla_sushil@rediffmail.com7030499665

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026